Immunome Stock (NASDAQ:IMNM), Quotes and News Summary

Q: What sector and industry does Immunome (IMNM) operate in?

Immunome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immunome Stock (NASDAQ: IMNM) stock price, news, charts, stock research, profile.

Open	$14.930
Close	$14.800
Volume / Avg.	935.341K / 751.153K
Day Range	14.660 - 15.730
52 Wk Range	4.500 - 30.958
Market Cap	$881.168M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	6.62%
Days to Cover	6.04

Recent News

Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?

In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting some setbacks in market expectations regarding interest rate reductions.

Piero Cingari

Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

Avi Kapoor

Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?

The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the highs of 2021. David Prince, professional trader at T3 Trading Group, joined Benzinga's PreMarket Prep on Tuesday and discussed the biotech industry and Viking Therapeutics and Immunome as notable recent movers.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Jan

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Immunome (IMNM) stock?

You can purchase shares of Immunome (NASDAQ: IMNM) through any online brokerage.

View our list of the best stock brokerages.

Who are Immunome's (IMNM) competitors?

Other companies in Immunome’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL), Centessa Pharmaceuticals (NASDAQ:CNTA) and Burning Rock Biotech (NASDAQ:BNR).

What is the target price for Immunome (IMNM) stock?

The latest price target for Immunome (NASDAQ: IMNM) was reported by JP Morgan on Tuesday, April 30, 2024. The analyst firm set a price target for 24.00 expecting IMNM to rise to within 12 months (a possible 63.27% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Immunome (IMNM)?

The stock price for Immunome (NASDAQ: IMNM) is $14.7 last updated May 15, 2024 at 4:20 PM EDT.

Does Immunome (IMNM) pay a dividend?

There are no upcoming dividends for Immunome.

When is Immunome (NASDAQ:IMNM) reporting earnings?

Immunome’s Q2 earnings are confirmed for Wednesday, August 7, 2024.

Is Immunome (IMNM) going to split?

There is no upcoming split for Immunome.

What sector and industry does Immunome (IMNM) operate in?

Immunome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-